Weight-based, anti-Xa guided enoxaparin after spine trauma surgery: target attainment and safety in a retrospective cohort - Takeaways - MDSpire

Weight-based, anti-Xa guided enoxaparin after spine trauma surgery: target attainment and safety in a retrospective cohort

  • By

  • Dallas L. Sheinberg

  • David Travis Johnston

  • Brendan T. O'Reilly

  • Gabriel Galan Castro

  • Jawad R. Khazaal

  • Joseph S. Withrow

  • Duncan J. Trimble

  • Ankush Chandra

  • Anthony J. Lim

  • Derek S. Sheinberg

  • Jennifer Zaragoza

  • Wen Li

  • John R. Williams

  • June 24, 2026

  • 0 min

Share

  • 1

    Patients undergoing surgery for traumatic spine injuries have a high risk of venous thromboembolism (VTE), with rates reported between 8% to 10%.

  • 2

    A retrospective cohort study evaluated anti-Xa-guided enoxaparin dosing in postoperative spine trauma patients to assess target attainment and safety outcomes.

  • 3

    Symptomatic VTE rates were similar between the anti-Xa cohort and the fixed dose cohort, at 1.1% and 1.6%, respectively.

  • 4

    In the anti-Xa cohort, 28% of patients required dose escalation, and no postoperative epidural hematomas were reported.

  • 5

    The study found that anti-Xa-guided dosing did not increase bleeding requiring transfusion compared to fixed dosing.

Original Source(s)

Related Content